Showing results (401-410 of 3,148) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|April 9, 2019
Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastomaJubayer A Hossain, Md A Latif, Lars A R Ystaas, et al.Neuro-Oncology|June 28, 2017
CD70, a novel target of CAR T-cell therapy for gliomasLinchun Jin, Haitao Ge, Yu Long, et al.Neuro-Oncology|May 5, 2017
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendrogliomaAlissa A Thomas, Lauren E Abrey, Robert Terziev, et al.Neuro-Oncology|May 9, 2017
Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrenceÜmmügülsüm Yesilöz, Elmar Kirches, Christian Hartmann, et al.Neuro-Oncology|July 2, 2017
Cost-effectiveness of radiation and chemotherapy for high-risk low-grade gliomaYushen Qian, Satoshi Maruyama, Haju Kim, et al.Neuro-Oncology|May 26, 2018
Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironmentWouter B L van den Bossche, Anne Kleijn, Charlotte E Teunissen, et al.Neuro-Oncology|May 10, 2018
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine gliomaNalin Gupta, Liliana C Goumnerova, Peter Manley, et al.Neuro-Oncology|May 24, 2019
Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastomaShuang G Zhao, Menggang Yu, Daniel E Spratt, et al.Neuro-Oncology|May 30, 2019
Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumorsHui Chen, Cheddhi Thomas, Felipe Andres Munoz, et al.Neuro-Oncology|May 12, 2019
Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patientsNorbert Galldiks, Marcus Unterrainer, Natalie Judov, et al.Pageof 315